Chemed (CHE) reported $2.5B in revenue for fiscal 2025, +4.1% year on year. That ranks #1204 by revenue among 2853 SEC filers and #107 in Healthcare. Net income was $265,238, a net margin of 0.0%. Revenue has grown 5.4% a year on average since 2016 ($1.6B then). The fiscal 2025 balance sheet shows $1.5B in total assets, $74.5M in cash and $92.5M in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenues | $2.5B | +4.1% | FY20252025-12-31 |
| Gross profit | Not reported | — | |
| Operating incomeOperatingIncomeLoss | $338M | −7.7% | FY20252025-12-31 |
| Net incomeNetIncomeLoss | $265,238 | −12.2% | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $388M | −7.0% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $62.8M | +26.8% | FY20252025-12-31 |
| Total assetsAssets | $1.5B | −7.8% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $979M | −12.5% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $74.5M | −58.2% | FY20252025-12-31 |
| Long-term debtLongTermDebtNoncurrent | $92.5M | −50.0% | FY20222022-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $658M | $66.3M | Open → |
| Q2 20262026-06-30 | $673M | $67.7M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 120 of 161 companies compared | 0.0% | |
| Operating marginRank 63 of 160 companies compared | 13.4% | |
| Cash as share of revenueRank 142 of 160 companies compared | 2.9% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Chemed Corp
- Ticker
- CHE
- Exchange
- NYSE
- SIC classification
- Services-Home Health Care Services (8082)
- Fiscal year end
- 12-31
- CIK
- 0000019584
Filings
- 10-QJul 31, 2026Open filing →
- 10-QApr 28, 2026Open filing →
- 10-KFeb 27, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Envista HoldingsNVST | $2.7B | $47.0M |
| InsuletPODD | $2.7B | $247M |
| Medpace HoldingsMEDP | $2.5B | $451M |
| ChemedCHE | $2.5B | $265,238 |
| Teladoc HealthTDOC | $2.5B | −$200M |
| Aveanna HealthcareAVAH | $2.4B | $225,034 |
| Royalty PharmaRPRX | $2.4B | $771M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Chemed — Key figures |url=https://companiesranked.com/en/company/chemed |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Chemed — Key figures. CompaniesRanked. https://companiesranked.com/en/company/chemedBibTeX
@misc{companiesranked-en-company-chemed-2026,
author = {{CompaniesRanked}},
title = {{Chemed — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/chemed}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001562762-26-000020 · February 27, 2026
{{cite web |title=Chemed — Key figures — 10-K (0001562762-26-000020) |url=https://www.sec.gov/Archives/edgar/data/19584/000156276226000020/che-20251231x10k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-27}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.